Methylation status of RB1 promoter in Indian retinoblastoma patients

被引:15
作者
Joseph, B
Mamatha, G
Raman, G
Shanmugam, MP
Kumaramanickavel, G
机构
[1] Vis Res Fdn, Dept Genet & Mol Biol, Madras 600006, Tamil Nadu, India
[2] Med Res Fdn, Dept Vitreoretina, Madras, Tamil Nadu, India
关键词
RB1; promoter; methylation; bisulfite modification; methylation specific PCR;
D O I
10.4161/cbt.3.2.620
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Retinoblastoma can arise due to mutational inactivation or methylation of RB1 gene promoter. A 600-bp CpG island consisting of the essential promoter is present at the 5' end of RB1 gene. Hypermethylation of the CpG island within the RB1 promoter region has been described in unilateral retinoblastoma. In vitro and in vivo studies have suggested that methylation of the RB1 promoter dramatically reduces gene activity. In the present study methylation status of the CpG island within the promoter region of RB1 gene has been evaluated by methylation specific polymerase chain reaction to define the molecular mechanism responsible for retinoblastoma in Indian patients. One unilateral and two bilateral nonhereditary patients had methylation of the RB1 promoter region in which 6.6% of our patients had complete methylation of the RB1 promoter region. This study shows methylation of RB1 promoter is not a major mechanism for retinoblastoma patients in India. Methylation analysis is used in genetic counseling of the family.
引用
收藏
页码:184 / 187
页数:4
相关论文
共 35 条
[1]   DNA hypermethylation in tumorigenesis - epigenetics joins genetics [J].
Baylin, SB ;
Herman, JG .
TRENDS IN GENETICS, 2000, 16 (04) :168-174
[2]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[3]   DNA methylation of retinoic acid receptor β in breast cancer and possible therapeutic role of 5-aza-2′-deoxycytidine [J].
Bovenzi, V ;
Lê, NLO ;
Cóté, S ;
Sinnett, D ;
Momparler, LF ;
Momparler, RL .
ANTI-CANCER DRUGS, 1999, 10 (05) :471-476
[4]  
Choy KW, 2002, INVEST OPHTH VIS SCI, V43, P1344
[5]  
Choy Kwong Wai, 2002, Hum Mutat, V20, P408, DOI 10.1002/humu.9077
[6]   Aberrant CpG-island methylation has non-random and tumour-type-specific patterns [J].
Costello, JF ;
Frühwald, MC ;
Smiraglia, DJ ;
Rush, LJ ;
Robertson, GP ;
Gao, X ;
Wright, FA ;
Feramisco, JD ;
Peltomäki, P ;
Lang, JC ;
Schuller, DE ;
Yu, L ;
Bloomfield, CD ;
Caligiuri, MA ;
Yates, A ;
Nishikawa, R ;
Huang, HJS ;
Petrelli, NJ ;
Zhang, XL ;
O'Dorisio, MS ;
Held, WA ;
Cavenee, WK ;
Plass, C .
NATURE GENETICS, 2000, 24 (02) :132-138
[7]  
Dobrovic A, 1997, CANCER RES, V57, P3347
[8]  
Edmunds SC, 2002, INVEST OPHTH VIS SCI, V43, P2845
[9]   Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors [J].
Esteller, M ;
Silva, JM ;
Dominguez, G ;
Bonilla, F ;
Matias-Guiu, X ;
Lerma, E ;
Bussaglia, E ;
Prat, J ;
Harkes, IC ;
Repasky, EA ;
Gabrielson, E ;
Schutte, M ;
Baylin, SB ;
Herman, JG .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2000, 92 (07) :564-569
[10]  
Esteller M, 2000, CANCER RES, V60, P2368